BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23745949)

  • 1. Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile.
    Dizdarevic S; Aplin M; Ryan N; Holt SG; Goldberg L; Miles KA; Peters AM
    Drug Metab Lett; 2012; 6(4):242-6. PubMed ID: 23745949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
    Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
    J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
    Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
    Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary elimination rate of inhaled 99mTc-sestamibi radioaerosol is delayed in healthy cigarette smokers.
    Ruparelia P; Cheow HK; Evans JW; Banney L; Shankar S; Szczepura KR; Swift AE; Ballinger JR; Hartman NG; Chilvers ER; Peters AM
    Br J Clin Pharmacol; 2008 Apr; 65(4):611-4. PubMed ID: 18279466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old tracer for a new purpose: potential role for 99mTc-2-Methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant care.
    Dizdarevic S; Aplin M; Newport MJ; Ryan N; Holt S; Goubet S; Goldberg L; Miles KA; Peters AM
    Nucl Med Commun; 2014 Oct; 35(10):1058-66. PubMed ID: 25025147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of P-glycoprotein function inhibition with cyclosporine A on the biodistribution of Tc-99m sestamibi.
    Kabasakal L; Halaĉ M; Nisli C; Oguz O; Onsel C; Civi G; Uslu I
    Clin Nucl Med; 2000 Jan; 25(1):20-3. PubMed ID: 10634525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.
    Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH
    Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of scintigraphic findings of oral malignant tumours with a new scanning agent of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (Tc-99m-MIBI).
    Sato T; Kawabata Y; Saigo Y; Iwashita Y; Suenaga S; Indo H; Hamahira S; Kawano K; Nitta T; Morita Y; Majima H; Sugihara K
    Dentomaxillofac Radiol; 2006 Jan; 35(1):24-9. PubMed ID: 16421260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
    Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
    Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
    Wong M; Evans S; Rivory LP; Hoskins JM; Mann GJ; Farlow D; Clarke CL; Balleine RL; Gurney H
    Clin Pharmacol Ther; 2005 Jan; 77(1):33-42. PubMed ID: 15637529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of permeability-glycoprotein (P-gp) and uptake of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI) in malignant tumour of the head and neck.
    Sato T; Kawabata Y; Nitta T; Saigo Y; Iwashita Y; Suenaga S; Hamahira S; Indo H; Morita Y; Majima HJ; Sugihara K
    Dentomaxillofac Radiol; 2005 Sep; 34(5):274-8. PubMed ID: 16120876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
    Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the uptake and clearance of Tc-99m MIBI, Tl-201 and Ga-67 in drug-resistant lymphoma cell lines.
    Tsai SC; Shiau YC; Wang JJ; Ho YJ; Kao CH
    Cancer Lett; 2001 Oct; 171(2):147-52. PubMed ID: 11520598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
    Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
    Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failure.
    Chesser AM; Carroll MC; Lightowler C; Macdougall IC; Britton KE; Baker LR
    Nephrol Dial Transplant; 1997 Jan; 12(1):97-100. PubMed ID: 9027781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive
    Dugonjić S; Šišić M; Radulović M; Ajdinović B
    Hell J Nucl Med; 2017; 20(1):46-50. PubMed ID: 28315908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
    Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescintigraphic morphine application for abdominal adenocarcinoma imaging, with technetium-99m methoxy isobutyl isonitrile.
    Ferlitsch A; Steindl-Munda P; Haefner M; Peck-Radosavljevic M; Madl C; Pötzi R; Homoncik M; Weidekamm C; Granegger S; Sinzinger H
    Hell J Nucl Med; 2007; 10(1):14-8. PubMed ID: 17450244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma.
    Kim YS; Cho SW; Lee KJ; Hahm KB; Wang HJ; Yim H; Jin YM; Park CH
    Clin Nucl Med; 1999 Nov; 24(11):874-9. PubMed ID: 10551471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Cancer Lett; 2000 May; 153(1-2):95-100. PubMed ID: 10779636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.